Zanamivir. 4-guanidino Neu5Ac2en, GG 167, GR 121167, GR 121167X, Relenza.
D000998:Antiviral Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004347:Drug Interactions; D006146:Guanidines; D006801:Humans; D007251:Influenza, Human / Q000188:drug therapy* / Q000517:prevention & control / Q000821:virology; D009975:Orthomyxoviridae / Q000187:drug effects; D011714:Pyrans; D012794:Sialic Acids / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D053243:Zanamivir
D000998:Antiviral Agents; D006146:Guanidines; D011714:Pyrans; D012794:Sialic Acids; D053243:Zanamivir